MC1R

Chr 16AR

melanocortin 1 receptor

Also known as: CMM5, MSH-R, SHEP2

This intronless gene encodes the receptor protein for melanocyte-stimulating hormone (MSH). The encoded protein, a seven pass transmembrane G protein coupled receptor, controls melanogenesis. Two types of melanin exist: red pheomelanin and black eumelanin. Gene mutations that lead to a loss in function are associated with increased pheomelanin production, which leads to lighter skin and hair color. Eumelanin is photoprotective but pheomelanin may contribute to UV-induced skin damage by generating free radicals upon UV radiation. Binding of MSH to its receptor activates the receptor and stimulates eumelanin synthesis. This receptor is a major determining factor in sun sensitivity and is a genetic risk factor for melanoma and non-melanoma skin cancer. Over 30 variant alleles have been identified which correlate with skin and hair color, providing evidence that this gene is an important component in determining normal human pigment variation. [provided by RefSeq, Jul 2008]

OMIMResearchGenerating clinical summary…
MultiplemechanismARLOEUF 1.976 OMIM phenotypes
Clinical SummaryMC1R
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
2 unique Pathogenic / Likely Pathogenic· 496 VUS of 823 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.97LOEUF
pLI 0.000
Z-score -2.21
OE 1.97 (1.121.97)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
-2.34Z-score
OE missense 1.46 (1.331.61)
299 obs / 204.9 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?1.97 (1.121.97)
00.351.4
Missense OE?1.46 (1.331.61)
00.61.4
Synonymous OE?1.39
01.21.6
LoF obs/exp: 12 / 6.1Missense obs/exp: 299 / 204.9Syn Z: -3.14

This gene — mechanism propensity

DN
0.7326th %ile
GOF
0.84top 5%
LOF
0.2776th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

823 submitted variants in ClinVar

Classification Summary

Likely Pathogenic2
VUS496
Likely Benign244
Benign34
Conflicting46
2
Likely Pathogenic
496
VUS
244
Likely Benign
34
Benign
46
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
0
0
0
Likely Pathogenic
2
0
0
0
2
VUS
34
401
54
7
496
Likely Benign
0
17
4
223
244
Benign
0
1
30
3
34
Conflicting
46
Total3641988233822

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

40 pathogenic / likely-pathogenic (of 64) ClinVar copy-number / structural variants overlap MC1R — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

MC1R · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →